Chester County News and Community Website
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced that all 84 clinical sites in its pivotal Phase 3 study for early Alzheimer’s disease (AD) are now fully activated and …
Annovis Bio Reaches Key Milestone as Alzheimer’s Phase 3 Trial Gains Momentum Read More MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced new clinical findings indicating that its lead candidate, buntanetap, reduces inflammation and improves cellular health in patients with Alzheimer’s disease, suggesting …
Annovis Bio Reports Promising Biomarker Results Showing Anti-Inflammatory, Neuroprotective Effects of Buntanetap in Alzheimer’s Patients Read More
WEST BRANDYWINE, PA — Freedom Village at Brandywine announced it raised more than $6,000 in September to support the Alzheimer’s Association, surpassing its original fundraising goal. The community’s efforts culminated …
Freedom Village at Brandywine Raises Over $6,000 for Alzheimer’s Research Read More MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the publication of a peer-reviewed article in Biomolecules detailing the pharmacokinetic profile of a newly developed crystal form of buntanetap, its …
Annovis Bio Publishes Data on New Crystal Form of Lead Alzheimer’s Drug Read More
More than 7 million Americans have Alzheimer’s disease, according to a 2025 report from the Alzheimer’s Association. The emotional toll of watching a loved one struggle with the memory loss, …
Financial Steps to Prepare for Alzheimer’s and Dementia Read More
WILMINGTON, DE — The Delaware Community Foundation (DCF) has announced a five-year, $13.1 million investment in the Delaware Center for Cognitive Aging Research (DECCAR) at the University of Delaware, marking …
Delaware Community Foundation Commits $13.1 Million to Alzheimer’s Research Read More MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has published new research in the journal Biomolecules detailing the pharmacokinetic profile of a new crystal form of buntanetap, its lead drug …
Annovis Bio Publishes Data on New Crystal Form of Alzheimer’s Drug Candidate Read More MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the successful transfer and rewrite of all its intellectual property protections to cover a newly developed crystalline form of its lead drug …
Annovis Bio Secures Full Patent Protection for New Crystal Form of Alzheimer’s Drug Buntanetap Read More
WEST BRANDYWINE, PA — Freedom Village at Brandywine joined the Alzheimer’s Association’s annual initiative, The Longest Day, raising over $1,300 to support dementia awareness and research. Held on June 20, …
Freedom Village at Brandywine Raises Over $1,300 for Alzheimer’s Research Read More MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has announced its participation in the prestigious Alzheimer’s Association International Conference (AAIC) 2025. The global event, set to take place from July …
Annovis Bio to Present Key Findings at Alzheimer’s Association International Conference Read More